Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study
- PMID: 26462857
- PMCID: PMC4604215
- DOI: 10.1136/bmj.h5162
Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study
Erratum in
-
Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study.BMJ. 2015 Nov 19;351:h6282. doi: 10.1136/bmj.h6282. BMJ. 2015. PMID: 26586674 No abstract available.
Abstract
Objective: To compare the safety and efficacy of hysteroscopic sterilization with the "Essure" device with laparoscopic sterilization in a large, all-inclusive, state cohort.
Design: Population based cohort study.
Settings: Outpatient interventional setting in New York State.
Participants: Women undergoing interval sterilization procedure, including hysteroscopic sterilization with Essure device and laparoscopic surgery, between 2005 and 2013.
Main outcomes measures: Safety events within 30 days of procedures; unintended pregnancies and reoperations within one year of procedures. Mixed model accounting for hospital clustering was used to compare 30 day and 1 year outcomes, adjusting for patient characteristics and other confounders. Time to reoperation was evaluated using frailty model for time to event analysis.
Results: We identified 8048 patients undergoing hysteroscopic sterilization and 44,278 undergoing laparoscopic sterilization between 2005 and 2013 in New York State. There was a significant increase in the use of hysteroscopic procedures during this period, while use of laparoscopic sterilization decreased. Patients undergoing hysteroscopic sterilization were older than those undergoing laparoscopic sterilization and were more likely to have a history of pelvic inflammatory disease (10.3% v 7.2%, P<0.01), major abdominal surgery (9.4% v 7.9%, P<0.01), and cesarean section (23.2% v 15.4%, P<0.01). At one year after surgery, hysteroscopic sterilization was not associated with a higher risk of unintended pregnancy (odds ratio 0.84 (95% CI 0.63 to 1.12)) but was associated with a substantially increased risk of reoperation (odds ratio 10.16 (7.47 to 13.81)) compared with laparoscopic sterilization.
Conclusions: Patients undergoing hysteroscopic sterilization have a similar risk of unintended pregnancy but a more than 10-fold higher risk of undergoing reoperation compared with patients undergoing laparoscopic sterilization. Benefits and risks of both procedures should be discussed with patients for informed decisions making.
© Mao et al 2015.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures
Comment in
-
More data needed on hysteroscopic compared with laparoscopic sterilisation.Evid Based Med. 2016 Apr;21(2):78. doi: 10.1136/ebmed-2015-110347. Epub 2016 Jan 8. Evid Based Med. 2016. PMID: 26747872 No abstract available.
Similar articles
-
The feasibility, safety, and effectiveness of hysteroscopic sterilization compared with laparoscopic sterilization.Am J Obstet Gynecol. 2017 Nov;217(5):570.e1-570.e6. doi: 10.1016/j.ajog.2017.07.011. Epub 2017 Jul 27. Am J Obstet Gynecol. 2017. PMID: 28757140
-
Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes.JAMA. 2018 Jan 23;319(4):375-387. doi: 10.1001/jama.2017.21269. JAMA. 2018. PMID: 29362796 Free PMC article.
-
Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006-2010.Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:133-7. doi: 10.1016/j.ejogrb.2014.04.043. Epub 2014 May 14. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24993770
-
Current techniques and outcomes in hysteroscopic sterilization: current evidence, considerations, and complications with hysteroscopic sterilization micro inserts.Curr Opin Obstet Gynecol. 2017 Aug;29(4):218-224. doi: 10.1097/GCO.0000000000000369. Curr Opin Obstet Gynecol. 2017. PMID: 28537948 Review.
-
Female sterilization: update on clinical efficacy, side effects and contraindications.Minim Invasive Ther Allied Technol. 2014 Oct;23(5):261-70. doi: 10.3109/13645706.2014.901975. Epub 2014 Mar 28. Minim Invasive Ther Allied Technol. 2014. PMID: 24678788 Review.
Cited by
-
Recent developments have made female permanent contraception an increasingly attractive option, and pregnant women in particular ought to be counselled about it.Contracept Reprod Med. 2016 Dec 12;1:23. doi: 10.1186/s40834-016-0034-1. eCollection 2016. Contracept Reprod Med. 2016. PMID: 29201412 Free PMC article. Review.
-
Comparing options for females seeking permanent contraception in high resource countries: a systematic review.Reprod Health. 2021 Jul 20;18(1):154. doi: 10.1186/s12978-021-01201-z. Reprod Health. 2021. PMID: 34284794 Free PMC article.
-
Analysis of surgeries performed after hysteroscopic sterilization as tabulated from 3,803 Essure patient experiences.Obstet Gynecol Sci. 2017 May;60(3):296-302. doi: 10.5468/ogs.2017.60.3.296. Epub 2017 May 15. Obstet Gynecol Sci. 2017. PMID: 28534016 Free PMC article.
-
Surgical excision of Essure® devices with ESHRE Class IIb uterine malformation: sequential hysteroscopic-laparoscopic approach to the septate uterus.Facts Views Vis Obgyn. 2016 Mar 28;8(1):49-52. Facts Views Vis Obgyn. 2016. PMID: 27822350 Free PMC article.
-
Safety reporting of Essure medical device: a qualitative and quantitative assessment on the FDA manufacturer and user facility device experience database in 2018.Front Reprod Health. 2023 Jul 13;5:1172927. doi: 10.3389/frph.2023.1172927. eCollection 2023. Front Reprod Health. 2023. PMID: 37519343 Free PMC article.
References
-
- Jones J, Mosher W, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. Natl Health Stat Report 2012;(60):1-25. - PubMed
-
- US Food and Drug Administration. Essure system - P020014. 2002. www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsa....
-
- GlobeNewswire. Conceptus(R) receives CE mark for transvaginal ultrasound confirmation for Essure(R) procedure. 2011. http://globenewswire.com/news-release/2011/02/24/440957/214723/en/Concep....
-
- Hurskainen R, Hovi SL, Gissler M, et al. Hysteroscopic tubal sterilization: a systematic review of the Essure system. Fertil Steril 2010;94:16-9. - PubMed
-
- Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med 1997;336:762-7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources